Xiaozhang Zheng

2PUBLICATIONS
6CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 20, 2025
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2.

Philip N Collier, Xiaozhang Zheng, Melissa Ford

|Aug 16, 2024
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases.

Xiaozhang Zheng, Nan Ji, Veronica Campbell

Pageof 1

Frequent Collaborators

1 joint publications

Matthew M Weiss

1 joint publications

Philip N Collier

1 joint publications

Joseph D Growney

1 joint publications

Atanu Paul